These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15078651)

  • 1. Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials.
    Halpern SD; Karlawish JH; Casarett D; Berlin JA; Asch DA
    Arch Intern Med; 2004 Apr; 164(7):801-3. PubMed ID: 15078651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and Ethics of Incentives for Research Participation: 2 Randomized Clinical Trials.
    Halpern SD; Chowdhury M; Bayes B; Cooney E; Hitsman BL; Schnoll RA; Lubitz SF; Reyes C; Patel MS; Greysen SR; Mercede A; Reale C; Barg FK; Volpp KG; Karlawish J; Stephens-Shields AJ
    JAMA Intern Med; 2021 Nov; 181(11):1479-1488. PubMed ID: 34542553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiency.
    Halpern SD; Karlawish JH; Casarett D; Berlin JA; Townsend RR; Asch DA
    Am Heart J; 2003 Dec; 146(6):985-92. PubMed ID: 14660989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulated payments for living kidney donation: an empirical assessment of the ethical concerns.
    Halpern SD; Raz A; Kohn R; Rey M; Asch DA; Reese P
    Ann Intern Med; 2010 Mar; 152(6):358-65. PubMed ID: 20231566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized evaluation of trial acceptability by INcentive (RETAIN): Study protocol for two embedded randomized controlled trials.
    Krutsinger DC; McMahon J; Stephens-Shields AJ; Bayes B; Brooks S; Hitsman BL; Lubitz SF; Reyes C; Schnoll RA; Ryan Greysen S; Mercede A; Patel MS; Reale C; Barg F; Karlawish J; Polsky D; Volpp KG; Halpern SD
    Contemp Clin Trials; 2019 Jan; 76():1-8. PubMed ID: 30414865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Informative inducement: study payment as a signal of risk.
    Cryder CE; John London A; Volpp KG; Loewenstein G
    Soc Sci Med; 2010 Feb; 70(3):455-464. PubMed ID: 19926187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic vulnerability and payment for research participation.
    Gelinas L; White SA; Bierer BE
    Clin Trials; 2020 Jun; 17(3):264-272. PubMed ID: 32063065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of risk and monetary payment on the research participation decision making process.
    Bentley JP; Thacker PG
    J Med Ethics; 2004 Jun; 30(3):293-8. PubMed ID: 15173366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participants' Perspectives on Payment for Research Participation: A Qualitative Study.
    Largent EA; Eriksen W; Barg FK; Greysen SR; Halpern SD
    Ethics Hum Res; 2022 Nov; 44(6):14-22. PubMed ID: 36316972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Our flawed approach to undue inducement in medical research.
    Lee E
    Bioethics; 2019 Jan; 33(1):13-18. PubMed ID: 30014475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Payment expectations for research participation among subjects who tell the truth, subjects who conceal information, and subjects who fabricate information.
    Devine EG; Knapp CM; Sarid-Segal O; O'Keefe SM; Wardell C; Baskett M; Pecchia A; Ferrell K; Ciraulo DA
    Contemp Clin Trials; 2015 Mar; 41():55-61. PubMed ID: 25530307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paying Research Participants: Regulatory Uncertainty, Conceptual Confusion, and a Path Forward.
    Largent EA; Fernandez Lynch H
    Yale J Health Policy Law Ethics; 2017; 17(1):61-141. PubMed ID: 29249912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploitation in payments to research subjects.
    Phillips T
    Bioethics; 2011 May; 25(4):209-19. PubMed ID: 19438444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undue inducement: the only objection to payment?
    VanderWalde A
    Am J Bioeth; 2005; 5(5):25-7. PubMed ID: 16179303
    [No Abstract]   [Full Text] [Related]  

  • 15. Children in Social Research: Do Higher Payments Encourage Participation in Riskier Studies?
    Taplin S; Chalmers J; Hoban B; McArthur M; Moore T; Graham A
    J Empir Res Hum Res Ethics; 2019 Apr; 14(2):126-140. PubMed ID: 30735083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undue fear of inducements in research in developing countries.
    Arnason G; Van Niekerk A
    Camb Q Healthc Ethics; 2009 Apr; 18(2):122-9. PubMed ID: 19250565
    [No Abstract]   [Full Text] [Related]  

  • 17. Paying hypertension research subjects.
    Casarett D; Karlawish J; Asch DA
    J Gen Intern Med; 2002 Aug; 17(8):650-2. PubMed ID: 12213148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When Does the Amount We Pay Research Participants Become "Undue Influence"?
    Williams EP; Walter JK
    AMA J Ethics; 2015 Dec; 17(12):1116-21. PubMed ID: 26698584
    [No Abstract]   [Full Text] [Related]  

  • 19. Payment to healthy volunteers in clinical research: the research subject's perspective.
    Czarny MJ; Kass NE; Flexner C; Carson KA; Myers RK; Fuchs EJ
    Clin Pharmacol Ther; 2010 Mar; 87(3):286-93. PubMed ID: 20090675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misconceptions about coercion and undue influence: reflections on the views of IRB members.
    Largent E; Grady C; Miller FG; Wertheimer A
    Bioethics; 2013 Nov; 27(9):500-7. PubMed ID: 22493972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.